Ads
related to: eczema atopic dermatitis treatment- Home
Official Patient Website—
Get Treatment Info Today.
- Treatment Support
Discover Educational Resources
& Get Financial Support Information
- FAQs
Find Answers To Your Questions
& Understand Treatment Now
- Support Resources
Sign Up And Learn More About The
Patient Education Program Today.
- Getting Started
Learn More About Dosing Schedules
Find Answers To Your Questions
- Sign Up
Register Or Activate Your Card—
Find Out If You're Eligible Today.
- Home
Search results
...-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment...
Clearfield Progress· 18 hours agoThe data of long-term treatment with stapokibart demonstrated sustained efficacy and favorable safety profile in adult patients with moderate-to-severe AD, and no new...
Keymed reports positive efficacy of stapokibart in Phase III clinical trial
Clinical Trials Arena via Yahoo Finance· 8 hours agoStapokibart (CM310) is a highly efficient, humanised...receive stapokibart 300mg or placebo every...
J&J to acquire experimental eczema drug for $1.25B
NJBIZ· 4 days agoJohnson & Johnson plans to pay $1.25 billion for the rights to an experimental eczema treatment. The New Brunswick-based pharma giant announced the...
J&J acquires experimental skin disorder drug for $1.25 billion
Reuters· 6 days ago, opens new tab on Tuesday agreed to acquire the rights to an experimental skin disorder treatment...
Study finds 1.5 percent ruxolitinib cream safe, effective for teens with eczema
Medical Xpress· 2 days agoLong-term intermittent use of ruxolitinib cream is well tolerated and provides disease control in...
J&J Acquires Experimental Eczema Drug in $1.25 Billion Cash Deal
Bloomberg· 6 days agoHave a confidential tip for our reporters? Johnson & Johnson agreed to pay $1.25 billion for the...
Tapinarof Cream Effective For AD, Down to Age 2 Years
Medscape· 6 days agoResults from two phase 3 trials showed that topical tapinarof, once a day, was effective and safe in patients with atopic dermatitis as young as 2 years old.
J&J gains another bispecific antibody with $1.25B skin drug buy
BioPharma Dive via Yahoo Finance· 6 days agoThe acquisition hands J&J a drug known as NM26 that’s ready for Phase 2 testing in atopic dermatitis...
Indoor tanning and eczema: Benefits, risks, and tanning tips
Medical News Today· 6 days agoModerate sun exposure and phototherapy may help improve eczema. Phototherapy uses controlled...
Dupilumab: Future Treatment for Pediatric Alopecia Areata?
Medscape· 6 days agoChildren with concomitant atopic dermatitis (AD) and alopecia areata (AA) who were treated with...
Ads
related to: eczema atopic dermatitis treatment